New MDRTB Treatment Program (1)

New MDRTB Treatment Program (1) - Trial for new...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Trial for new drug-resistant TB treatment to begin By Jean-Louis Santini | AFP –  A global health alliance Monday unveiled plans for the first clinical  tests of a new  treatment regimen  for tuberculosis, including for  patients with resistance to existing multidrug programs. The  TB Alliance , which is funded by several governments and  foundations, said the new drug combination offers promise in the  fight against TB, which kills an estimated 1.4 million people each  year, mostly in Africa. Health experts said the new program could be particularly useful for  an estimated 650,000 people around the world who suffer from  multidrug-resistant TB (MDR-TB), a number expected to rise, and  could shorten treatment times. "There is new momentum and new hope in TB research, as shown by  this and several other novel regimen trials that will soon be launched,"  said Mel Spigelman, president and chief executive of the TB Alliance. "This novel TB drug regimen has the potential to unlock a new and 
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 04/05/2012 for the course HLTH 311 taught by Professor Anderson during the Spring '12 term at BYU.

Page1 / 3

New MDRTB Treatment Program (1) - Trial for new...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online